SARS-CoV-2 Infection in patients with autoimmune hepatitis

Marjot, Thomas, Buescher, Gustav, Sebode, Marcial, Barnes, Eleanor, Barritt, Alfred, Armstrong, Matthew, Baldelli, Luke, Kennedy, James, mercer, Carolyn, Ozga, Ann-Kathrin, Casar, Christian, Schramm, Christoph, Moon, Andrew, Webb, Gwilym, Lohse, Ansgar

Marjot, Thomas, Buescher, Gustav, Sebode, Marcial, Barnes, Eleanor, Barritt, Alfred, Armstrong, Matthew, Baldelli, Luke, Kennedy, James, mercer, Carolyn, Ozga, Ann-Kathrin, Casar, Christian, Schramm, Christoph, Moon, Andrew, Webb, Gwilym, Lohse, Ansgar.

Gut ; 70(Suppl 4):A7-A8, 2021.

Article in English | ProQuest Central | ID: covidwho-1504357

ABSTRACT

ABSTRACT

OTH-1 Figure 1(A) AIH v non-AIH CLD (B) AIH v non-CLD[Figure omitted. See PDF]ConclusionDespite immunosuppressive treatment, AIH patients were not at increased risk of adverse outcomes from COVID-19 compared to other causes of CLD and to matched cases without liver disease.

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: Gut Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: Gut Year: 2021 Document Type: Article